Overview

Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness and safety of vortioxetine, once daily (QD), in patients with Major Depressive Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda
Collaborator:
H. Lundbeck A/S
Treatments:
Vortioxetine